SMI 8'533 0.3%  Dow 16'461 -0.9%  Nikkei 15'139 -0.4%  Euro 1.2064 0.0%  BuySell
SPI 8'413 0.4%  EStoxx50 3'024 0.5%  Gold 1'240 -0.1%  Dollar 0.9527 -0.1%  BuySell
DAX 8'992 0.6%  FTSE100 6'382 -0.3%  Öl 84.7 0.1%  Pfund 1.5251 -0.3%  BuySell

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Kurse + Charts + Realtime News + Analysen Fundamental Unternehmen zugeh. Wertpapiere Aktion
Kurs + Chart Chart (gross) News + Adhoc Bilanz/GuV Termine Strukturierte Produkte Portfolio
Times + Sales Chartvergleich Analysen Schätzungen Profil Watchlist
Börsenplätze Realtime Push Kursziele Dividende/GV
Disclaimer

Diesen Hinweis zukünftig nicht mehr anzeigen.

OK
Abbrechen
Historisch Analysen

Analysen zu Biomarin Pharmaceutical Inc.

06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
29.10.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.09.08 Biomarin Pharmaceutical outperform William Blair
27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
02.07.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.06.08 Biomarin Pharmaceutical hold Citigroup Corp.
29.05.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
28.02.08 Biomarin Pharmaceutical buy Merrill Lynch & Co., Inc.
28.02.08 Biomarin Pharmaceutical neutral UBS AG
27.02.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
09:37 British American Tobacco overweight JP Morgan Chase & Co.
09:33 Infineon Technologies overweight HSBC
09:25 Klöckner & Outperform BNP PARIBAS
09:18 ABB Neutral JP Morgan Chase & Co.
08:44 Krones kaufen DZ-Bank AG
07:50 Porsche Hold UBS AG
22.10.14 Aurubis kaufen Bankhaus Lampe KG
22.10.14 Natus Medical Buy ROTH Capital Partners, LLC
22.10.14 Peugeot Hold S&P Capital IQ
22.10.14 Biogen Idec Outperform Robert W. Baird & Co. Incorporated
22.10.14 Hawaiian Buy Deutsche Bank AG
22.10.14 Cree Hold Deutsche Bank AG
22.10.14 Packaging Hold Deutsche Bank AG
22.10.14 Hess Equal weight Barclays Capital
22.10.14 Wayfai a Mkt Perform William Blair
22.10.14 VMware Buy UBS AG
22.10.14 Telus Neutral UBS AG
22.10.14 Rogers Communications Neutral UBS AG
22.10.14 BCE Neutral UBS AG
22.10.14 Acadia Healthcare Buy UBS AG
22.10.14 Hess Buy UBS AG
22.10.14 Chesapeake Energy Buy UBS AG
22.10.14 Lumber Liquidators Buy Canaccord Adams
22.10.14 Tom Tailor buy Close Brothers Seydler Research AG
22.10.14 Travelers Companies Neutral MKM Partners
22.10.14 Sartorius vz Halten Norddeutsche Landesbank (Nord/LB)
22.10.14 GlaxoSmithKline buy S&P Capital IQ
22.10.14 Reckitt Benckiser Group Halten Independent Research GmbH
22.10.14 BHP Billiton buy S&P Capital IQ
22.10.14 Ethan Allen Interiors Buy Dougherty & Company LLC
22.10.14 AIXTRON Hold Kepler Cheuvreux
22.10.14 Daimler buy Kepler Cheuvreux
22.10.14 Cree Hold Canaccord Adams
22.10.14 Hawaiian Market Perform Cowen and Company, LLC
22.10.14 STRATEC Biomedical buy Kepler Cheuvreux
22.10.14 Intuitive Surgical Sell CRT Capital
22.10.14 Lafarge buy Kepler Cheuvreux
22.10.14 DEUTZ Hold Kepler Cheuvreux
22.10.14 GulfMark Offshor a Neutral Global Hunter Securities
22.10.14 Materialise NV (spons ADRs) Perform Oppenheimer & Co. Inc.
22.10.14 Coca-Cola Hold Gabelli & Co
22.10.14 Callon Petroleum Buy Maxim Group
22.10.14 National Fuel Gas Buy Maxim Group
22.10.14 EQT Buy Maxim Group
22.10.14 Discover Financial Services Outperform Oppenheimer & Co. Inc.
22.10.14 Discover Financial Services Outperform FBR Capital
22.10.14 Sonic Outperform Oppenheimer & Co. Inc.
22.10.14 Discover Financial Services Outperform RBC Capital Markets
22.10.14 Sucampo Pharmaceutical a Buy ROTH Capital Partners, LLC
22.10.14 ABB Halten Independent Research GmbH